Apogem Capital’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-85,091
| Closed | -$454K | – | 4 |
|
|
2022
Q3 | $454K | Sell |
85,091
-64,256
| -43% | -$343K | 0.45% | 71 |
|
|
2022
Q2 | $596K | Buy |
149,347
+45,305
| +44% | +$181K | 0.54% | 61 |
|
|
2022
Q1 | $462K | Buy |
104,042
+17,312
| +20% | +$76.9K | 0.32% | 103 |
|
|
2021
Q4 | $347K | Buy |
86,730
+30,077
| +53% | +$120K | 0.23% | 120 |
|
|
2021
Q3 | $497K | Buy |
56,653
+10,922
| +24% | +$95.8K | 0.32% | 107 |
|
|
2021
Q2 | $518K | Buy |
45,731
+9,421
| +26% | +$107K | 0.33% | 98 |
|
|
2021
Q1 | $431K | Sell |
36,310
-19,511
| -35% | -$232K | 0.29% | 105 |
|
|
2020
Q4 | $383K | Buy |
+55,821
| New | +$383K | 0.25% | 111 |
|